期刊文献+

223例结核分枝杆菌耐药分析 被引量:4

Drug-resistance analysis of 233 cases of Mycobacterium tuberculosis
原文传递
导出
摘要 目的:研究和监测结核分枝杆菌不同药物浓度下耐药情况,为临床合理用药提供依据。方法:采用绝对浓度间接法,对利福喷丁、异烟肼、对氨基水杨酸、链霉素、吡嗪酰胺、乙胺丁醇、利福平、丁胺卡那、帕司烟肼、丙硫异烟胺、卷曲霉素、氧氟沙星12种药物的药敏试验。结果:223例肺结核患者痰分枝杆菌标本中,总耐药率为93.72%、其中初治患者为92.54%,复治为95.51%;单耐药率为10.31%;耐多药率为37.22%,初治为28.36%,复治为50.56%;广泛耐药率8.07%,约占耐多药的21.69%。结论:结核分枝杆菌培养在不同浓度下进行结核药敏试验,可以科学、合理地指导临床用药。 Objective:To study and monitor the drug resistance of mycobacterium tuberculosis at different concentrations,ao as to provide basis for the rational drug use in clinic.Methods: With absolute concentration method,Rifapentine,Isoniazid,Para-aminosalicylic acid,Streptomycin,Pyrazinamide,Ethambutol,Rifampin,Amikacin,Pasiniazid,Prothionamide,Capreomycin and Levofloxacin were conducted susceptibility test.Results: In 223 sputum specimens of Mycobacterium tuberculosis patients,the total drug resistance rate was 93.72%,patients with early treatment(92.54%),retreated patients(95.51%);single drug resistance rate(10.31%),MDR rate(37.22%),initial treatment(28.36%),retreated patients(50.56%);Extensively drug-resistance rate(8.07%),accounting for 21.69% of MDR.Conclusion: Mycobacterium tuberculosis drug susceptibility test at different concentrations can guide scientific and rational use of drugs in clinic.
出处 《中国卫生检验杂志》 北大核心 2012年第9期2222-2224,共3页 Chinese Journal of Health Laboratory Technology
关键词 分枝杆菌 结核 浓度 耐药 Mycobacterium Tuberculosis Concentration Drug resistance
  • 相关文献

参考文献8

二级参考文献27

共引文献319

同被引文献48

  • 1梅建,薛桢,沈鑫,沈国妙,桂晓红,沈梅,高谦.原发性耐药是耐药结核病产生的重要原因[J].中华结核和呼吸杂志,2006,29(2):75-78. 被引量:103
  • 2金嘉琳,张文宏,翁心华,胡忠义,陈澍,邵凌云.华东地区耐药结核分枝杆菌katG基因的变异[J].中华传染病杂志,2006,24(5):301-305. 被引量:10
  • 3王庆枫,高孟秋,马丽萍,吴晓光,朱莉贞.利福喷汀治疗耐利福平肺结核的疗效分析[J].中国防痨杂志,2006,28(6):382-385. 被引量:14
  • 4中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:1-8.
  • 5全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010,25-33.
  • 6Andrews JR,Gandhi NR, Moodley P,et al. (2008) ExogenousRe- infection as a Cause of Multidrug Resistant and Extensively Drug Resistant Tuberculosis in Rural South Africa [ J ]. J hffect Dis 198:1582 - 1589.
  • 7WHO. Global tuberculosis report 2013[EB/OL]. (2013-11-01)[2014-07-04]. http://www.who.int/tb/publications/global_report/en.
  • 8WHO. Global tuberculosis control and patient care: a ministerial meeting of high M/XDR-TB burden countries[EB/OL]. (2009-04-01)[2014-07-04]. http://www.who.int/tb_beijingmeeting/en.
  • 9Guo Y, Zhou Y, Wang C, et al. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system[J]. Int J Tuberc Lung Dis, 2009, 13(7): 914-920.
  • 10Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis[J]. Int J Tuberc Lung Dis, 2009, 13(11): 1320-1330.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部